Objective: Adenosine and inosine accumulate in tissue during periods of ischemia and both molecules have been shown to degranulate mast cells in the hamster cheek pouch via activation of an A3 receptor. An A2-mediated inhibitory action of adenosine on mast cell degranulation has also been reported (16), and the objective of this research was to investigate the role of adenosine A2 receptors in modulating inosine-induced mast cell degranulation and subsequent vasoconstriction of microvessels. Methods: Cheek pouches of the Golden hamster were prepared for in vivo microscopy. Adenosine, inosine, and other agents were applied either globally in the superfusion solution or to selected regions of the tissue by pipette. Results: Micropipette application of 10−4 M inosine to periarteriolar mast cells caused a vasoconstriction and an associated mast cell degranulation in 71% of the arterioles tested. The average diameter reduction was 29 ± 5%. To establish a modulatory role for the A2 receptor, low doses of adenosine (100 nM and 10 nM) were applied globally via the superfusion prior to inosine stimulation. This adenosine pretreatment resulted in a decrease in the incidence of the inosineinduced vasoconstriction (17% and 31%), as well as smaller constrictions (0.5 ± 1% and 7 ± 3%). Mast cell degranulation was also reduced by pretreatment with adenosine, as evidenced by a decreased number of mast cells exhibiting ruthenium red dye uptake. The inhibitory effect of adenosine could be eliminated by pretreatment with the nonselective A1/A2 antagonist 8-(p-sulfophenyl) theophylline, which restored the inosine-induced responses to control values. To demonstrate that the effect was A2α-mediated, vessels were pretreated with the selective A2α agonist 2-[4-(2-carboxyethyl) phenethylamino]-5'-N-ethylcarboxamidoadenosine (CGS21680). Following this treatment, constriction in response to microapplication of inosine (10−4 M) occurred in only 11% of the vessels tested; the average constriction was reduced to 2 ± 2% and no mast cell degranulation was observed. Conclusions: We conclude that mast cell degranulation can be inhibited via activation of an adenosine A2α receptor; which activation occurs at a lower concentration of adenosine than stimulatory A3 receptor activation. This finding may have implications for the pathology of ischemia. Microcirculation (2000) 7, 129-135.
Microcirculation
Volume 7, 2000 - Issue 2
7
Views
0
CrossRef citations to date
0
Altmetric
Research Article
Activation of Adenosine A2a Receptors Inhibits Mast Cell Degranulation and Mast Cell-Dependent Vasoconstriction
M.S. FENSTER Departments of Cardiology, University of Virginia Health Sciences Center, Charlottesville, VA, USA
, R.K. SHEPHERD Department of Biochemistry, Medical College of Virginia, Richmond, VA, USA
, J. LINDEN Departments of Cardiology, University of Virginia Health Sciences Center, Charlottesville, VA, USA
& B.R. DULING Molecular Physiology and Biological Physics, University of Virginia Health Sciences Center, Charlottesville, VA, USA
Research Article
Activation of Adenosine A2a Receptors Inhibits Mast Cell Degranulation and Mast Cell-Dependent Vasoconstriction
- References
- Citations
- Metrics
- Reprints & Permissions
- Get access /doi/pdf/10.1080/sj.mn.7300101?needAccess=true
Abstract
Reprints and Permissions
Please note: We are unable to provide a copy of the article, please see our help page How do I view content?
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
Permission can also be obtained via Rightslink. For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.